메뉴 건너뛰기




Volumn 1, Issue 2, 2003, Pages 259-266

The effect of new drug approvals on HIV mortality in the US, 1987-1998

Author keywords

Antiretroviral therapy; HIV drug approval; HIV mortality; Innovation; Pharmaceuticals; R D

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; OCTREOTIDE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EID: 0346620161     PISSN: 1570677X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-677X(02)00031-X     Document Type: Article
Times cited : (23)

References (10)
  • 1
    • 0029021863 scopus 로고
    • Trends in drug development costs, times, and risks
    • DiMasi, J.A., 1995. Trends in drug development costs, times, and risks. Drug Information Journal 29, 375-384.
    • (1995) Drug Information Journal , vol.29 , pp. 375-384
    • Dimasi, J.A.1
  • 2
    • 0003468422 scopus 로고    scopus 로고
    • UNAIDS, Geneva, Switzerland
    • Joint United Nations Programme on HIV/AIDS, 2000. Report on the global HIV/AIDS epidemic. UNAIDS, Geneva, Switzerland, 〈http://hivinsite.ucsf.edu/ InSite.jsp?page=pr-02-01&doc=2098.478b〉.
    • (2000) Report on the Global HIV/AIDS Epidemic
  • 3
    • 0029680124 scopus 로고    scopus 로고
    • Prevalence of HIV infection in the United States, 1984-1992
    • Karon, J.M., Rosenberg, P.S., McQuillan, G., 1996. Prevalence of HIV infection in the United States, 1984-1992. Journal of the American Medical Association 276, 126-131 (http://www.ama-assn.org/special/hiv/library/readroom/ jama96/oc5a84.htm).
    • (1996) Journal of the American Medical Association , vol.276 , pp. 126-131
    • Karon, J.M.1    Rosenberg, P.S.2    McQuillan, G.3
  • 4
    • 33748480942 scopus 로고    scopus 로고
    • Pharmaceutical knowledge-capital accumulation and longevity
    • Corrado, C., Haltiwanger, J., Sichel, D. (Eds.), University of Chicago Press, Chicago
    • Lichtenberg, F.R., 2002. Pharmaceutical knowledge-capital accumulation and longevity, 〈http://www.nber.org/~confer/2002/criws02/lichtenberg. pdf〉. In: Corrado, C., Haltiwanger, J., Sichel, D. (Eds.), Measuring Capital in the New Economy. University of Chicago Press, Chicago.
    • (2002) Measuring Capital in the New Economy
    • Lichtenberg, F.R.1
  • 5
    • 0032576426 scopus 로고    scopus 로고
    • Changing patterns of mortality across Europe in patients infected with HTV-1
    • November 28
    • Mocroft, A., et al., 1998. Changing patterns of mortality across Europe in patients infected with HTV-1. Lancet 352 (9142), 1725-1730 (November 28).
    • (1998) Lancet , vol.352 , Issue.9142 , pp. 1725-1730
    • Mocroft, A.1
  • 7
    • 0003982531 scopus 로고    scopus 로고
    • Public Health Service, Hyattsville, MD
    • National Center for Health Statistics, 2001. Healthy People 2000 Final Review. Public Health Service, Hyattsville, MD, 〈http://www.cdc.gov/nchs/ data/hp2000/hp2k01.pdf〉.
    • (2001) Healthy People 2000 Final Review
  • 8
    • 2642709177 scopus 로고    scopus 로고
    • Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
    • March 26
    • Palella, F.J., et al., 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 338 (13), 853-860 (March 26, 〈http://www.ama-assn.org/ special/hiv/library/scan/mar98/mar98f.htm〉).
    • (1998) New England Journal of Medicine , vol.338 , Issue.13 , pp. 853-860
    • Palella, F.J.1
  • 9
    • 0039287480 scopus 로고    scopus 로고
    • Pharmaceutical Research and Manufacturers Association, 2000. PhRMA Industry Profile 2000, 〈http://www. phrma.org/publications/publications/ profile00/index.phtml>.
    • (2000) PhRMA Industry Profile 2000


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.